|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zaravinos A: The regulatory role of
MicroRNAs in EMT and cancer. J Oncol. 2015:8658162015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saitoh M: Epithelial-mesenchymal
transition is regulated at post-transcriptional levels by
transforming growth factor-β signaling during tumor progression.
Cancer Sci. 106:481–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Horiguchi K, Sakamoto K, Koinuma D, Semba
K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K
and Saitoh M: TGF-β drives epithelial-mesenchymal transition
through δEF1-mediated downregulation of ESRP. Oncogene.
31:3190–3201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shirakihara T, Kawasaki T, Fukagawa A,
Semba K, Sakai R, Miyazono K, Miyazawa K and Saitoh M:
Identification of integrin α3 as a molecular marker of cells
undergoing epithelial-mesenchymal transition and of cancer cells
with aggressive phenotypes. Cancer Sci. 104:1189–1197. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawataki T, Yamane T, Naganuma H,
Rousselle P, Andurén I, Tryggvason K and Patarroyo M: Laminin
isoforms and their integrin receptors in glioma cell migration and
invasiveness: Evidence for a role of alpha5-laminin(s) and
alpha3beta1 integrin. Exp Cell Res. 313:3819–3831. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shirakihara T, Horiguchi T, Miyazawa M,
Ehata S, Shibata T, Morita I, Miyazono K and Saitoh M: TGF-β
regulates isoform switching of FGF receptors and
epithelial-mesenchymal transition. EMBO J. 30:783–795. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brehar FM, Ciurea AV, Chivu M, Zarnescu O,
Radulescu R and Dragu D: The development of xenograft glioblastoma
implants in nude mice brain. J Med Life. 1:275–286. 2008.PubMed/NCBI
|
|
11
|
Sinh ND, Endo K, Miyazawa K and Saitoh M:
Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2,
dependent on ERK1/2 activity, in breast cancer cells. Cancer Sci.
108:952–960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukagawa A, Ishii H, Miyazawa K and Saitoh
M: δEF1 associates with DNMT1 and maintains DNA methylation of the
E-cadherin promoter in breast cancer cells. Cancer Med. 4:125–135.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelial-to-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Miyazawa K and Miyazono K: Autocrine TGF-beta signaling maintains
tumorigenicity of glioma-initiating cells through Sry-related
HMG-box factors. Cell Stem Cell. 5:504–514. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Li H, Yan W, Yang P, Bao Z, Zhang C,
Jiang T and You Y: Genetic and clinical characteristics of primary
and secondary glioblastoma is associated with differential
molecular subtype distribution. Oncotarget. 6:7318–7324.
2015.PubMed/NCBI
|
|
17
|
Ohashi S, Natsuizaka M, Wong GS,
Michaylira CZ, Grugan KD, Stairs DB, Kalabis J, Vega ME, Kalman RA,
Nakagawa M, et al: Epidermal growth factor receptor and mutant p53
expand an esophageal cellular subpopulation capable of
epithelial-to-mesenchymal transition through ZEB transcription
factors. Cancer Res. 70:4174–4184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siebzehnrubl FA, Silver DJ, Tugertimur B,
Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT,
Kupper MD, Neal D, et al: The ZEB1 pathway links glioblastoma
initiation, invasion and chemoresistance. EMBO Mol Med.
5:1196–1212. 2013. View Article : Google Scholar : PubMed/NCBI
|
